Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03143621 · ClinicalTrials.gov registry record · NA

The Effect of Coffee After Resection of Small Bowel

A NA study, sponsored by Mount Carmel Health System.

Completed
Registry status
NA
Development phase
79
Enrollment target

NCT03143621 is a NA study that has completed, run by Mount Carmel Health System. The registered enrollment target is 79 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03143621, a NA study, has completed, sponsored by Mount Carmel Health System.

COMPLETED
Registry status
NA
Development phase
79 participants
Enrollment target

Study Summary

Post-operative ileus ("post-op ileus") is a condition which can occur after surgery. This means that the bowels stop working correctly and food and liquids will not pass through in the normal manner. Post-op ileus can be uncomfortable and require a longer hospital stay until the bowels begin to function correctly again. Currently there are no effective methods for preventing post-op ileus. Some studies suggest there is a benefit from drinking coffee following colon or gynecological cancer surgeries with very little risk. However, the effects of coffee following small bowel surgery have not been studied. This randomized, controlled trial will compare the outcomes of patients who receive coffee during their hospital stay after small bowel surgery to similar patients who receive warm water. About 60 patients will be in each group. The main outcomes are time until the nasogastric tube is removed and length of hospital stay.

Interventions

  • OTHER Water
  • DIETARY_SUPPLEMENT Coffee

Trial Details

FieldValue
Enrollment Target 79 participants
Start Date 2017-11-15
Est. Completion 2022-09-30
Phase NA

Sponsor

Mount Carmel Health System

8 total trials

What the Registry Record Tells You About NCT03143621

The ClinicalTrials.gov registry entry for NCT03143621 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 79 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mount Carmel Health System, which has 8 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Water is the first listed.

NCT03143621 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03143621 about?

NCT03143621 is a clinical study titled "The Effect of Coffee After Resection of Small Bowel". Post-operative ileus ("post-op ileus") is a condition which can occur after surgery. This means that the bowels stop working correctly and food and liquids will not pass through in the normal manner. Post-op ileus can be uncomfortable and require a longer hospital stay until the bowels begin to func...

What is the current status of trial NCT03143621?

This trial is currently completed. It is a NA study. The enrollment target is 79 participants. The study started on 2017-11-15. Estimated completion is 2022-09-30.

What interventions are being tested in trial NCT03143621?

The interventions under investigation include: Water (OTHER), Coffee (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT03143621?

This trial is sponsored by Mount Carmel Health System, which has 8 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.